Skip to content

BSX

Boston Scientific Corporation

EBITDA, 2025
$5.0B
YoY, 2025
+28.6%
5-year CAGR
+36.7%
10-year CAGR
+26.2%

EBITDA

EBITDA by fiscal year

PeriodEBITDAYoY
2025$5.0B+28.6%
2024$3.9B+9.4%
2023$3.5B+27.1%
2022$2.8B+21.5%
2021$2.3B+119.8%
2020$1.0B−58.7%
2019$2.5B+5.3%
2018$2.4B+12.8%
2017$2.1B+68.7%
2016$1.3B+159.7%
2015$486M+14.6%
2014$424M−47.6%
2013$809M—
2012−$3.2B—
2011$1.6B+913.1%
2010$160M—
2009−$60M—
2008−$641M—
2007$904M—